Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

Background: The prevalence of pre-treatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI) agents is increasing in sub-Saharan Africa, which may decrease the effectiveness of efavirenz-based antiretroviral therapy (ART) programs. However, due to recent safety concern...

Full description

Bibliographic Details
Main Authors: Horacio A. Duarte, Joseph B. Babigumira, Eva A. Enns, David C. Stauffer, Robert W. Shafer, Ingrid A. Beck, Louis P. Garrison, Jr., Michael H. Chung, Lisa M. Frenkel, Eran Bendavid
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:EClinicalMedicine
Subjects:
HIV
Pretreatment drug resistance
Drug resistance testing
Cost-effectiveness analysis
Dolutegravir-based ART
Efavirenz-based ART
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020300997

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020300997

Similar Items